Assignment of Assignor's Interest

Recorded: 2026-06-10 Received: 2026-06-10 Pages: 3

Assignor

BRIDGEBIO PHARMA CANADA, ULC

Executed: 2026-04-14

Assignee

PORTAL THERAPEUTICS, INC.

3160 PORTER DRIVE, SUITE 250, PALO ALTO, CA, 94304, UNITED STATES

Covered Properties (2)

Amido Pyrido[3,4-B]Indole-1,4-Dione Compounds for Treatment of Porphyrias

Application: 19/368,941 →

Purine-Core Inhibitors of HSP90 and Their Use in Treating Cancer

Application: 12/494,917 →